CrunchBase is hiring! Check out our open positions →

General Information
edit

Website	telormedix.com
Phone	41-(0)91-610-7000
Email	telormedix@telorm...
Employees

Offices
edit

Bioggio, CHE

Via della Posta 10
Bioggio, CH-6934, CHE

Funding
edit

TOTAL	$8.3M
FUNDING TOTAL	$8.3M
Series B, 2/12 Aravis Ventures ProQuest Investments	$8.3M

Tags
edit

Telormedix
edit

Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases.

Recent Milestones
edit

Telormedix received $8.3M in Series B funding. (2/28/12)

Posted 1/10/12 at 8:12pm via onbiovc.com

Videos

Screenshots
edit

Above: Telormedix
Uploaded: 1/11/12

Sources

Telormedix, SA.: Series B $8.3M (onbiovc.com) [edit]

Edit This Page
Last Edited 2/28/12

Revision History

Sharing

External Links

edit

CrunchBase API

JSON Representation of this page.
More API docs »

General Information edit

Offices edit

Funding edit

Tags edit

Telormedix edit

Recent Milestones edit